Sep-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Chronic Health has demonstrated a consistent performance in the Arizona market, particularly within the Tincture & Sublingual category. Over the months from June to September 2025, the brand maintained a strong hold on the second position in this category, indicating a stable consumer base and possibly effective brand loyalty or product satisfaction. Despite a slight decrease in sales from July to August, the brand managed to keep its ranking steady, which could suggest that their market strategy focuses on maintaining a consistent presence rather than aggressive growth. This stability in ranking, even with fluctuating sales figures, is a notable achievement in a competitive market.
Conversely, the Topical category in Arizona presents a different narrative for Chronic Health. While the brand started off strong with a second-place ranking from June to August, there was a notable drop to fourth place by September. This shift might indicate increased competition or a change in consumer preferences within this category. The decline in sales over the same period aligns with this drop in ranking, suggesting that while the brand has a significant presence, it may need to reassess its strategy to regain its earlier standing. The absence of Chronic Health in the top three by September highlights the dynamic nature of the topical market and the challenges brands face in sustaining top-tier positions.
Competitive Landscape
In the competitive landscape of the Topical category in Arizona, Chronic Health has experienced notable fluctuations in its market position from June to September 2025. Initially holding a strong second place, Chronic Health maintained this position through July and August, but saw a decline to fourth place by September. This drop in rank coincided with a decrease in sales, suggesting potential challenges in maintaining consumer interest or facing increased competition. Notably, Müv / MUV emerged as a significant competitor, climbing from sixth place in June to secure the second position by September, indicating a robust upward trajectory in sales and market presence. Meanwhile, iLava and Tru Infusion maintained relatively stable rankings, with iLava reclaiming its third-place position in September. The competitive dynamics suggest that while Chronic Health was a strong contender earlier in the year, the brand may need to reassess its strategies to regain its footing against the rising competition.

Notable Products
In September 2025, the Indica THC Glycerin Tincture (100mg THC, 1oz) maintained its position as the top-performing product for Chronic Health, with sales reaching 518 units. Consistently holding the second spot is the CBD/THC 1:1 Sleep Well Tincture (100mg CBD, 100mg THC, 1oz), followed closely by the CBD/THC 1:1 Glycerin Tincture (100mg CBD, 100mg THC, 1oz) in third place. The CBD/THC 1:1 Pain Relief Ointment (175mg CBD, 175mg THC, 2oz) and the CBD/THC 1:1 Pain Relief Ointment (45mg CBD, 45mg THC) remained in fourth and fifth positions, respectively. Notably, these rankings have remained unchanged since June 2025, indicating a stable preference among consumers for these top products.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.







